RecruitingNCT07328178

Analysis of the Role of IgE Proteoforms in Health and Disease

Sponsor

KU Leuven

Enrollment

200 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Anaphylaxis Healthy Control Mastocytosis Chronic Spontaneous Urticaria (CSU)X-linked Agammaglobulinaemia Venom Allergy Type I Allergy Medication Allergy Hereditary Alpha-Tryptasemia

Summary

The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of anaphylaxis, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), and patients undergoing desensitization for venom or medication allergy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood sample collection for people with anaphylaxis, chronic spontaneous urticaria (csu), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.